Other

Dataset Information

0

IL-1 Signaling Blockade in Human Lymphocytic Myocarditis


ABSTRACT: Lymphocytic myocarditis is characterized by infiltration of lymphocytes and macrophages. Current treatment for lymphocytic myocarditis is limited to corticosteroids and a proportion of patients progress to require heart transplantation or durable mechanical circulatory support within a year. Increasing attention is directed toward targeting pro-inflammatory mediators in myocarditis. One promising candidate is IL-1. Here, we investigated a patient with underlying autoimmune disease and biopsy confirmed lymphocytic myocarditis who was initially treated with corticosteroids and experienced clinical deterioration requiring temporary mechanical circulatory support. Rilonacept was consequently administered as a salvage therapy. Pathologically, rilonacept reduced inflammation and fibrosis. We performed spatial transcriptomics (ST) on formalin-fixed paraffin-embedded endomyocardial biopsy samples to further investigate how the cardiac immune landscape is modulated by rilonacept.

ORGANISM(S): Homo sapiens

PROVIDER: GSE296452 | GEO | 2025/07/09

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-12-31 | GSE278521 | GEO
2020-11-01 | E-MTAB-8867 | biostudies-arrayexpress
| PRJNA1259402 | ENA
2018-02-13 | GSE104423 | GEO
2018-09-28 | GSE120567 | GEO
2024-12-30 | PXD058698 | Pride
| PRJNA493608 | ENA
2023-07-01 | GSE227437 | GEO
2012-01-19 | GSE35182 | GEO
2024-06-20 | GSE262658 | GEO